NAVIGATING OZEMPIC FOR WEIGHT LOSS AND DIABETES MANAGEMENT IN OLDER ADULTS

Around one in three older adults has obesity, and one in five has a known diagnosis of diabetes. For these adults, GLP-1 medications like Ozempic, which can lower blood sugar and lead to weight loss, may be a good option. But are they riskier to take once you reach age 65? Let’s explore.

UNDERSTANDING OZEMPIC

Ozempic (semaglutide) belongs to the class of GLP-1 medications designed to regulate insulin secretion and appetite. Administered via subcutaneous injection once a week, Ozempic is prescribed alongside lifestyle changes to manage blood sugar levels effectively.

Initially developed for type 2 diabetes management, Ozempic aids in controlling blood sugar by increasing insulin levels and reducing appetite post-meals. It also prolongs stomach emptying and triggers signals of fullness to the brain, contributing to weight loss.

SAFETY CONSIDERATIONS FOR OLDER ADULTS

Research suggests that Ozempic is generally safe and effective for individuals over 65. However, older adults may experience more severe side effects, such as nausea, vomiting, and diarrhea, and are more likely to discontinue treatment due to these effects.

Furthermore, older adults are at increased risk of hypoglycemia (low blood sugar) and may experience muscle mass loss and bone density reduction with the rapid weight loss associated with Ozempic use.

MITIGATING RISKS

To minimize risks associated with Ozempic use in older adults, certain precautions are advised:

1. Extra Monitoring: Healthcare providers may recommend additional monitoring for older adults taking Ozempic to manage potential side effects and adjust treatment accordingly.
2. Nutritional Support: Proper nutrition and hydration are crucial to manage gastrointestinal side effects and mitigate health risks associated with muscle mass and bone density loss.
3. Strength Training: Incorporating resistance training into your exercise routine can help preserve muscle mass and bone strength, reducing the risk of falls and fractures.
4. Protein and Calcium Intake: Increasing daily protein and calcium intake can support muscle and bone health, respectively, aiding in the maintenance of overall health and well-being.

MEDICARE COVERAGE AND COST CONSIDERATIONS

Medicare coverage for Ozempic depends on various factors, including the purpose of prescription and individual insurance plans. While Ozempic may be covered for type 2 diabetes management, coverage for weight loss purposes may vary. Exploring potential savings options and insurance coverage can help mitigate out-of-pocket expenses.

IS OZEMPIC RIGHT FOR YOU?

Ozempic may be suitable for individuals with type 2 diabetes or obesity who struggle to manage their condition through lifestyle changes alone. However, individual health status, age, and medical history should be considered when determining the appropriateness of Ozempic use.

CONCLUSION

Ozempic offers promising benefits for older adults managing diabetes or obesity. By understanding the risks and benefits associated with its use, along with implementing appropriate precautions and lifestyle modifications, older adults can make informed decisions about incorporating Ozempic into their treatment regimen.

Call to Action

At Aktwisted Wellness, we are dedicated to helping you achieve your health goals through personalized and comprehensive care. If you are considering Ozempic for weight loss or diabetes management, contact us today to schedule a consultation. Our team of experts will guide you through the process, ensuring you make the best decision for your health and well-being.

Disclaimer:

This blog post is for informational purposes only and should not be construed as medical advice. Consult with your healthcare provider before starting any medication or treatment regimen. The information provided here is based on current research and expert opinions but should not replace personalized medical guidance.

SOURCES

1. Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., … & Wilding, J. P. H. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes randomized clinical trial. JAMA, 314(7), 687-699.
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., … & Skjøth, T. V. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
3. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
4. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., … & Rosenstock, J. (2020). Effect of subcutaneous semaglutide vs. placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA, 324(21), 2186-2195.
5. Ryan, D. H., & Yockey, S. R. (2017). Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Current Obesity Reports, 6(2), 187-194.